Coagulation-fibrinolysis abnormalities in poststroke patients.
Oztürk
S
S
Bruck
D
D
Feinberg
W M
WM
D001779:Blood Coagulation Factors; D002561:Cerebrovascular Disorders / Q000097:blood* / Q000150:complications; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000097:blood; D005342:Fibrinolysis; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000150:complications; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects; D012107:Research Design
D001779:Blood Coagulation Factors; D017395:Plasminogen Activator Inhibitor 1; D010975:Platelet Aggregation Inhibitors